Drug Profile
Gantenerumab companion diagnostic - Roche
Latest Information Update: 16 Aug 2012
Price :
$50
*
At a glance
- Originator Roche
- Class Monoclonal antibody diagnostics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Alzheimer's disease
Most Recent Events
- 07 Jun 2012 Investigation in early stage Alzheimer's disease (diagnosis) in Switzerland (unspecified route)